61 – 70 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden - An economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
(
- Contribution to journal › Article
-
Mark
Vertebroplasty and kyphoplasty in the fractured osteoporotic spine.
(
- Contribution to journal › Article
-
Mark
The risk and burden of vertebral fractures in Sweden
(
- Contribution to journal › Article
-
Mark
Epidemiology of osteoporotic fractures.
(
- Contribution to journal › Article
-
Mark
Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.
(
- Contribution to journal › Article
-
Mark
Long term effects of oestrogen therapy on bone loss in postmenopausal women: a 23 year prospective study.
(
- Contribution to journal › Article
-
Mark
A family history of fracture and fracture risk: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study
(
- Contribution to journal › Article
-
Mark
A meta-analysis of previous fracture and subsequent fracture risk
(
- Contribution to journal › Article